SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017729
Filing Date
2023-05-16
Accepted
2023-05-16 14:31:53
Documents
53
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 854309
2 ex31-1.htm EX-31.1 12759
3 ex31-2.htm EX-31.2 12771
4 ex32-1.htm EX-32.1 7928
  Complete submission text file 0001493152-23-017729.txt   4068011

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tsoi-20230331.xsd EX-101.SCH 25273
6 XBRL CALCULATION FILE tsoi-20230331_cal.xml EX-101.CAL 50385
7 XBRL DEFINITION FILE tsoi-20230331_def.xml EX-101.DEF 109088
8 XBRL LABEL FILE tsoi-20230331_lab.xml EX-101.LAB 254102
9 XBRL PRESENTATION FILE tsoi-20230331_pre.xml EX-101.PRE 203595
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 494051
Mailing Address 701 WILD ROSE LANE ELK CITY ID 83525
Business Address 701 WILD ROSE LANE ELK CITY ID 83525 (760) 295-7208
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (Filer) CIK: 0001419051 (see all company filings)

IRS No.: 451226465 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54554 | Film No.: 23926793
SIC: 3841 Surgical & Medical Instruments & Apparatus